AOD-9604 is an artificial fragment of the GH C-terminal peptide
When the benefit outweighs the side effect, and when it might not For most patients, the metabolic benefits of GLP-1 therapy, including improved cardiovascular risk factors, better insulin sensitivity, reduced visceral fat, and meaningful weight loss, far outweigh a temporary or modest change in libido
Postsurgical intestinal rehabilitation using semisynthetic glucagon-like peptide-2 analogue (sGLP-2) at a referral center: can patients achieve parenteral nutrition and sGLP-2 independency
Studies show oxidative degradation and peptide aggregation increase beyond this window, reducing bioavailability by 1020% or more depending on storage conditions
The company added that it will also sell brand-name versions of GLP-1 drugs, once supply rebounds